.webp)
Revvity Launches Signals BioDesign™ to Transform Biologics Research Workflows
A New Era for Molecular Cloning and Biologics Design Revvity, Inc. (NYSE: RVTY) has officially introduced Signals BioDesign™,...
Advancing Precision Oncology & Pathology – Atlanta CME Program 2026
A New Step Forward in Precision Oncology The field of precision oncology continues to evolve rapidly, driven by...
Breast Cancer Advances in Precision Oncology – Atlanta CME Program
Healthcare professionals are invited to join Advancing Precision Oncology & Pathology – Atlanta, a complimentary in-person educational program...
Small Molecules and Peptides for Advanced Biomedical Research
Small molecules and peptides are indispensable tools in modern biomedical research, drug discovery, and therapeutic development. From supporting...
Advancing Precision Cancer Care – Atlanta 2026
Advancing Precision Cancer Care – Atlanta will bring together leading oncology and pathology experts from across the Southeastern...
Revvity Signals 2025 Year in Review: AI, Unified Data, and the Future of Scientific Discovery
2025 was a landmark year for scientific innovation and digital transformation across the life sciences. From the first...
How to Measure the Kinetics of Targeted Protein Degradation
Targeted protein degradation is transforming modern drug discovery. Instead of simply blocking the activity of disease-related proteins, this...
How to Optimize Your Pipetting Technique for Challenging Liquids: Live Webinar
Accurate pipetting is fundamental to reliable experimental results, yet many laboratories struggle when working with viscous, volatile, foaming,...
19th Annual European Life Sciences CEO Forum 2026: Partnering, Investment, and Strategy in Zurich
The European Life Sciences CEO Forum (ELSF) returns for its 19th annual edition on March 4–5, 2026, taking...
Bio-Techne Launches Ultra-Sensitive Simple Plex Assays on Ella for Femtogram-Level Detection of Neurological Biomarkers
Bio-Techne Corporation has announced the launch of Simple Plex® Ultra-Sensitive Assays on the Ella Platform, marking a major...